Search
Returning search results with filters:
Remove filter for
Category: Biologic or vaccine
Remove filter for
Last updated: 2021
Clear all
Search filters
Type
Audience
Category
Issue
Last updated
Displaying 1 - 15 of 23 items.
COMIRNATY (COVID-19 Vaccine, mRNA, also referred to as Pfizer-BioNTech COVID-19 Vaccine): New Formulation for Use in Children Aged 5 Years to Less Than 12 Years
AlertHealth professional risk communication | 2021-11-19
Distribution of SPIKEVAX (elasomeran) COVID-19 Vaccine with English-only Vial and Carton Labels
AlertHealth professional risk communication | 2021-11-10
Health Canada is updating the labels of the Janssen and Vaxzevria (AstraZeneca) COVID-19 vaccines
AlertPublic advisory | 2021-11-09
Importation of Janssen COVID-19 Vaccine with European Union (EU) English-only Vial and Carton Labels
AlertHealth professional risk communication | 2021-11-05
Authorization of Sotrovimab for Injection for Use in Relation to the COVID-19 Pandemic
AlertHealth professional risk communication | 2021-10-04
One lot of the hypoglycemia treatment Glucagon recalled as it may pose serious health risks
AlertPublic advisory | 2021-09-25
Health Canada updates Pfizer-BioNTech COVID-19 vaccine label to reflect very rare reports of Bell's Palsy
AlertPublic advisory | 2021-08-06
Authorization of Casirivimab and Imdevimab with English-only Labels for Use in Relation to the COVID-19 Pandemic
AlertHealth professional risk communication | 2021-07-30
Health Canada updates Pfizer-BioNTech and Moderna COVID-19 vaccine labels to include information on myocarditis and pericarditis
AlertPublic advisory | 2021-06-30
AstraZeneca COVID-19 Vaccine and COVISHIELD: Risk of Capillary Leak Syndrome
AlertHealth professional risk communication | 2021-06-29
Health Canada issues label change on the AstraZeneca and COVISHIELD COVID-19 vaccines
AlertPublic advisory | 2021-06-29
Importation of COVID-19 Vaccine Moderna with up to 15 Doses per Vial and English-only Vial and Carton Labels (US-Labelled Supply)
AlertHealth professional risk communication | 2021-06-14
Bamlanivimab - Potential Risk of Treatment Failure Due to Circulation of Resistant SARS-CoV-2 Variants
AlertHealth professional risk communication | 2021-04-28
Importation of Janssen COVID-19 Vaccine with Two Types of English-only Vial and Carton Labels
AlertHealth professional risk communication | 2021-04-26
Janssen COVID-19 Vaccine and the Risk of Thrombosis with Thrombocytopenia
AlertHealth professional risk communication | 2021-04-26